Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yulia Nefedova

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Plos One|January 31, 2015
Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent mannerEileen R Grigson, Maria Ozerova, Alexandra Pisklakova, et al.
Cancer Research|October 19, 2005
Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathwayYulia Nefedova, Srinivas Nagaraj, Amsler Rosenbauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancerYulia Nefedova, Mei Huang, Sergei Kusmartsev, et al.
Molecular Cancer Therapeutics|December 17, 2010
Combined inhibition of Notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effectMing Li, Feng Chen, Nicholas Clifton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Activation of dendritic cells via inhibition of Jak2/STAT3 signalingYulia Nefedova, Pingyan Cheng, Daniele Gilkes, et al.
ACS Applied Nano Materials|January 30, 2023
Nitrogen-Doped Carbon Nanotube Cups for Cancer TherapySeth C Burkert, Xiaoyun He, Galina V Shurin, et al.
Molecular Cancer Therapeutics|May 7, 2020
A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple MyelomaMarina Li, Cindy Lin, Hui Deng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2013
Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrowIndu R Ramachandran, Anna Martner, Alexandra Pisklakova, et al.
Cancer Letters|December 8, 2015
Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapyIndu R Ramachandran, Thomas Condamine, Cindy Lin, et al.
The Journal of Clinical Investigation|March 9, 2023
Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesionsIrene Bertolini, Michela Perego, Yulia Nefedova, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Plos One|January 31, 2015
Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent mannerEileen R Grigson, Maria Ozerova, Alexandra Pisklakova, et al.
Cancer Research|October 19, 2005
Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathwayYulia Nefedova, Srinivas Nagaraj, Amsler Rosenbauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancerYulia Nefedova, Mei Huang, Sergei Kusmartsev, et al.
Molecular Cancer Therapeutics|December 17, 2010
Combined inhibition of Notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effectMing Li, Feng Chen, Nicholas Clifton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Activation of dendritic cells via inhibition of Jak2/STAT3 signalingYulia Nefedova, Pingyan Cheng, Daniele Gilkes, et al.
ACS Applied Nano Materials|January 30, 2023
Nitrogen-Doped Carbon Nanotube Cups for Cancer TherapySeth C Burkert, Xiaoyun He, Galina V Shurin, et al.
Molecular Cancer Therapeutics|May 7, 2020
A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple MyelomaMarina Li, Cindy Lin, Hui Deng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2013
Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrowIndu R Ramachandran, Anna Martner, Alexandra Pisklakova, et al.
Cancer Letters|December 8, 2015
Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapyIndu R Ramachandran, Thomas Condamine, Cindy Lin, et al.
The Journal of Clinical Investigation|March 9, 2023
Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesionsIrene Bertolini, Michela Perego, Yulia Nefedova, et al.
Pageof 6